The World Health Organization (WHO) has approved the emergency use of the Sinopharm Chinese COVID vaccine


The World Health Organization (WHO) has authorized the emergency use of the Chinese vaccine Sinopharm to prevent corona.

Sinopharm is the first Chinese vaccine authorized by the World Health Organization to be used regularly.

The Sinopharm vaccine is being administered to citizens in other countries including Pakistan.

The WHO has previously approved the use of Pfizer, AstraZeneca and others.

With the approval of the World Health Organization, Sinopharm has been added to COVEX, after which the vaccine, along with others around the world, will be distributed to poor countries under the COVEX program.

COVAX seeks to provide free vaccines to 92 low-income countries and assist another 99 countries and territories in obtaining them.

It was not immediately clear when the Chinese vaccine would be added to the COVAX lineup.

Senior WHO advisor Bruce Aylward said Sinopharm will have to say how many doses of its vaccine it will give to the programme, but added: “They are looking at trying to provide substantial help, make substantial doses available while, of course, trying to serve China’s population.”

“Its easy storage requirements make it highly suitable for low-resource settings,” a WHO statement said.

Following the approval, Tedros said its separate Strategic Advisory Group of Experts (SAGE) recommended that adults over the age of 18 receive two doses of the Sinopharm vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *